NDC 72162-2193-01 - Carbidopa and Levodopa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2193
- Requested NDC
- 72162-2193-01
- Package NDCs from labels
- 72162-2193-1, 72162-2193-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-07-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbidopa and Levodopa - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-07-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2193-1 | Carbidopa and Levodopa | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2193 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 101 | Current NDC, 1 package rows | 20231219_3b06a0e2-bec8-4178-942b-67eb47f2916e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2193-1 | EA - Each | 72162-2193 | 1c7774b0-99e6-471f-82fb-4a8d10e3ce2d | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 0c630a24-dc51-4601-a5d6-2f9e397a0449 | 2026-04-03 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 770ba054-fec4-4833-8096-85c3ce3ae830 | 2026-04-01 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Inc. | 9d4e886e-edec-471d-b619-bf4828a6b7ce | 2026-03-31 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Alembic Pharmaceuticals Inc. | ac18e5fa-e2ee-4aa5-8d0f-94b63a076e66 | 2026-03-30 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals NY LLC | 0eb24333-3c11-41dd-888d-3a30d3c9d188 | 2026-03-30 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Crocodile Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Crocodile Tears LLC | 4df29336-ea0c-0484-e063-6294a90a685a | 2026-03-26 | Warnings | 3NXW29V3WO |
| RYTARY | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | 2026-03-26 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | KC Pharmaceuticals, Inc | 4de5c844-85ca-ff9f-e063-6394a90ac12c | 2026-03-25 | Warnings | 3NXW29V3WO |
| Carbidopa, Levodopa, and Entacapone | CARBIDOPA, LEVODOPA, AND ENTACAPONE | Sandoz Inc | 9c16c0e0-3b97-486b-b7d5-579f5853e2c5 | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Duopa | CARBIDOPA AND LEVODOPA | AbbVie Inc. | 7066d371-dc6a-0d6f-7bed-e5dd4ee912da | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Safecor Health, LLC | 015bc056-ee86-4006-ae7c-689b95e566f4 | 2026-03-19 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | 3NXW29V3WO |
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Limited | 9ff83838-b7d0-4eec-98f2-fcc85789a189 | 2026-02-17 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Rising Pharma Holdings, Inc. | 302bfe03-d222-4a87-80ff-f2dbfb9a07f4 | 2026-01-27 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Inbrija | LEVODOPA | Merz Pharmaceuticals, LLC | a906f8e1-6e1c-480a-8276-c01bc65dd3be | 2026-01-16 | Warnings, Adverse reactions | 46627O600J |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | AvKARE | e232e055-7892-3541-e053-2995a90a1e74 | 2026-01-14 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | AvKARE | da471cd4-dcee-b026-e053-2a95a90a3d81 | 2026-01-14 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | AvKARE | 11e706c4-433c-1ea6-e063-6294a90ad360 | 2026-01-14 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| L-Dopa 1514 | L-DOPA | Professional Complementary Health Formulas | fd88cb05-2621-4582-80bf-02cf14519100 | 2026-01-08 | Warnings | 46627O600J |
| Discount Drug Mart Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Discount Drug Mart | f7fd53be-e501-d97f-e053-6394a90ad409 | 2025-12-30 | Warnings | 3NXW29V3WO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.